Data as of 2:25pm ET
| -0.43 / -1.50%|
The 10 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 42.30, with a high estimate of 70.59 and a low estimate of 28.26. The median estimate represents a +49.64% increase from the last price of 28.27.
The current consensus among 11 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.